Peter Traxler

6.2k citations

61 papers · 4.6k indexed · 1 hit paper · h-index 30

Impact in

Oncology top 2%
- HER2/EGFR in Cancer Research
Organic Chemistry top 2%
- Synthesis and biological activity
- Quinazolinone synthesis and applications

Papers in

Microbiology 6
- Actinomycetales infections and treatment 6
Oncology 28
- HER2/EGFR in Cancer Research 21

Co-authors: Elisabeth Buchdunger Pascal Furet Thomas Meyer Nicholas Lydon Helmut Mett Christoph Bock Johanna Klughammer Christian Schmidl
Journals: The Journal of Antibiotics (12 papers)Helvetica Chimica Acta (8 papers)Journal of Medicinal Chemistry (6 papers)Medicinal Research Reviews (3 papers)Expert Opinion on Therapeutic Targets (2 papers)
Partner nations: Switzerland United States Austria

In The Last Decade

Peter Traxler

61 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Pooled CRISPR screening with single-cell transcriptome readout 2017 · 655 citations

Peers

Countries citing papers authored by Peter Traxler

Since Specialization

Citations

This map shows the geographic impact of Peter Traxler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Traxler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Traxler more than expected).

Fields of papers citing papers by Peter Traxler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Traxler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Traxler. The network helps show where Peter Traxler may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Traxler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Traxler Line = papers co-authored together Peter Traxler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Integrated time-series analysis and high-content CRISPR screening delineate the dynamics of macrophage immune regulation Cell Systems ·Peter Traxler, A La Fianza, Lukas Folkman, Lisa E. Shaw, Victoria Fife, Amelie Nemc, Gurbani Nk, Chao Wang, Daniele Barreca, Nikolaus Fortelny, André F. Rendeiro, Florian Halbritter, Wolfgang Weninger, Thomas Decker, Matthias Farlik, Christoph Bock	2025	1
2	Pooled CRISPR screening with single-cell transcriptome readout Nature Methods ·Paul Datlinger, André F. Rendeiro, Christian Schmidl, Thomas Krausgruber, Peter Traxler, Johanna Klughammer, Linda C. Schuster, Abderrahim Cheikh, Donát Alpár, Christoph Bock Hit paper breakdown →	2017	655
3	Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor European Journal of Medicinal Chemistry ·J Joop Boersma, Urs Séquin, Guido Bold, Pascal Furet, Thomas Meyer, Peter Traxler	2004	56
4	AEE788 Cancer Research ·Peter Traxler, Peter R. Allegrini, Ralf Brandt, Josef Brueggen, Robert Cozens, Doriano Fabbro, Konstantina Grosios, Heidi A. Lane, Paul M.J. McSheehy, Jürgen Mestan, Thomas Meyer, Careen K. Tang, Markus Wartmann, Jeanette M. Wood, Giorgio Caravatti	2004	268
5	Tyrosine kinases as targets in cancer therapy – successes and failures Expert Opinion on Therapeutic Targets ·Peter Traxler	2003	187
6	Tyrosine kinase inhibitors: From rational design to clinical trials Medicinal Research Reviews ·Peter Traxler, Guido Bold, Elisabeth Buchdunger, Giorgio Caravatti, Pascal Furet, Paul W. Manley, Terence O’Reilly, Jeanette M. Wood, Juerg Zimmermann	2001	265
7	Molecular approaches to receptors as targets for drug discovery Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions ·Dean B. Evans, Peter Traxler, Carlos Garcı́a-Echeverrı́a	2000	4
8	Preparation of 4-(4′-Hydroxyanilino)-5-anilinophthalimide and 4,5-Bis-(4′-hydroxyanilino)-phthalimide by Microbial Hydroxylation Bioscience Biotechnology and Biochemistry ·Stefan Weidner, K. Goeke, Uwe Trinks, Peter Traxler, Sofía Camino, Oreste Ghisalba	1999	2
9	Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors Pharmacology & Therapeutics ·Peter Traxler, Pascal Furet	1999	322
10	Tyrosine kinase inhibitors in cancer treatment (Part II) Expert Opinion on Therapeutic Patents ·Peter Traxler	1998	59
11	Protein tyrosine kinase inhibitors in cancer treatment Expert Opinion on Therapeutic Patents ·Peter Traxler	1997	57
12	Synthesis of Modified Tripeptides and Tetrapeptides as potential bisubstrate inhibitors of the epidermal growth factor receptor protein tyrosine kinase Helvetica Chimica Acta ·Gérard Rossé, Urs Séquin, Helmut Mett, Pascal Furet, Peter Traxler, Heinz Fretz	1997	10
13	A strategy for screening anti-tumor drugs utilizing oncogenes encoded in retroviral vectors International Journal of Cancer ·Michael J. Corbley, Van Cherington, Peter Traxler, Nicholas Lydon, Thomas M. Roberts	1996	2
14	4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity. PubMed ·Elisabeth Buchdunger, Helmut Mett, Uwe Trinks, Urs Regenass, Marcel A. Müller, Thomas Meyer, Paul Beilstein, B. Wirz, Patricia Schneider, Peter Traxler	1995	24
15	Modelling study of protein kinase inhibitors: Binding mode of staurosporine and origin of the selectivity of CGP 52411 Journal of Computer-Aided Molecular Design ·Pascal Furet, Giorgio Caravatti, Nicholas Lydon, John P. Priestle, Janusz M. Sowadski, Uwe Trinks, Peter Traxler	1995	87
16	[(Alkylamino)methyl]acrylophenones: Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase Journal of Medicinal Chemistry ·Peter Traxler, Uwe Trinks, Elisabeth Buchdunger, Helmut Mett, Thomas Meyer, Marcel Mueller, Urs Regenass, Johannes Roesel, Nicholas Lydon	1995	72
17	Effect of a novel series of macrocyclic hypolipidemic agents on plasma lipid and lipoprotein levels of four non-primate species Atherosclerosis ·Jerry D. Gibson, Himanshu V. Kothari, Function A. Campbell, W. Robert Lee, Kenneth A. Poirier, Wilbur K. Sawyer, Saima Nazar, Peter Traxler, BO Dongshan, Miloš Grim	1992	7
18	Sulfonylbenzoyl-nitrostyrenes: Potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase Journal of Medicinal Chemistry ·Peter Traxler, E. Peelen, Sonia Torres González, Johanna Geissler, W. G. Kump, Thomas Meyer, Urs Regenass, Johannes Roesel, Nicholas Lydon	1991	49
19	Papulacandins - Synthesis and biological activity of papulacandin B derivatives. The Journal of Antibiotics ·Peter Traxler, W. TOSCH, O. Zák	1987	24
20	Papulacandins - The relationship between chemical structure and effect on glucan synthesis in yeast. The Journal of Antibiotics ·G.Y. Osmanova, Peter Traxler, W. Wehrli	1983	38

About Peter Traxler

Peter Traxler is a scholar working on Microbiology, Oncology, Hematology, Pharmacology and Organic Chemistry, having authored 61 papers that have together received 4.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (21 papers), PI3K/AKT/mTOR signaling in cancer (13 papers), Microbial Natural Products and Biosynthesis (11 papers), Quinazolinone synthesis and applications (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Click Chemistry and Applications (6 papers), Actinomycetales infections and treatment (6 papers) and Synthesis and biological activity (4 papers). The work is most often cited by research in Oncology (1.6k citations), Organic Chemistry (1.1k citations), Molecular Biology (2.7k citations), Microbiology (27 citations) and Hematology (357 citations). Peter Traxler has collaborated with scholars based in Switzerland, United States and Austria. Frequent co-authors include Elisabeth Buchdunger, Pascal Furet, Thomas Meyer, Nicholas Lydon, Pascal Furet, Helmut Mett, Christoph Bock, Johanna Klughammer, Christian Schmidl and Paul Datlinger. Their work appears in journals such as The Journal of Antibiotics, Helvetica Chimica Acta, Journal of Medicinal Chemistry, Medicinal Research Reviews and Expert Opinion on Therapeutic Targets.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact